Valproic acid, sodium butyrate, and Vorinostat (SAHA) are examples of HDAC inhibitors that are currently used to target depression, schizophrenia, BD, PTSD and are being preclinically explored for ASD (120). This evidence concerns the gene HDAC9 and schizophrenia.